Hamid O, Lewis KD, Weise A, McKean M, et al. Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. J Clin Oncol 2024 Jun 20:JCO2302172. doi: 10.1200/JCO.23.02172.
PMID: 38900987